RxDoctor Payments Data

Jennifer Fain

Nurse Practitioner · Welch, WVNPI 1679922132

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 33.7% of the total. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,187in general payments, 2019–2025

Across 233 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$999
  • Boehringer Ingelheim$735
  • GSK$256
  • Lilly USA, LLC$152
  • Abbott$78
  • plus $555 from 13 others

What the payments were for

  • Food & beverage$4,187100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,187 in reported general payments places this provider in the 95th percentile of 649 nurse practitioner providers in West Virginia.

See all nurse practitioner providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin91$80,444
OzempicSemaglutide70$80,088
Trelegy ElliptaFluticasone/Umeclidin/Vilanter72$51,235
FarxigaDapagliflozin Propanediol47$36,730
EliquisApixaban30$27,620
Breztri AerosphereBudesonide/Glycopyr/Formoterol34$26,530
MounjaroTirzepatide20$20,993
TradjentaLinagliptin16$16,548
Tresiba Flextouch U-200Insulin Degludec21$16,476
LinzessLinaclotide24$15,611
XareltoRivaroxaban18$13,593
VascepaIcosapent Ethyl15$8,640
Atrovent HfaIpratropium Bromide14$6,726
BrilintaTicagrelor11$6,661
SymbicortBudesonide/Formoterol Fumarate14$3,849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$735$96,992107 claims
Novo NordiskOzempic$999$80,08870 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$1,411$73,770106 claims
GSKTrelegy Ellipta$256$51,23572 claims
Lilly USA, LLCMounjaro$152$20,99320 claims
Johnson & JohnsonXarelto$29$13,59318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 649 nurse practitioner providers in West Virginia.

Other nurse practitioner in Welch

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →